CTLA4 and neoplasm: Non-clinical studies using B16–F10 melanoma demonstrated that localized injection of tumors with oncolytic Newcastle disease virus induced infiltration of tumor-specific CD4+ T cells and CD8+ T cells into both the injected tumor and distant tumors; this action increased the sensitivity of the tumors to systemic CTLA-4 blockade [10].